# Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer

> **NCT05618821** · PHASE2 · RECRUITING · sponsor: **Fujian Medical University** · enrollment: 68 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Indocyanine Green Tracer

## Key facts

- **NCT ID:** NCT05618821
- **Lead sponsor:** Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-03
- **Primary completion:** 2025-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2022-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05618821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05618821, "Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05618821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*